Publications
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | Second Faculty of Medicine
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
- Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
Loading network view...